Bure Equity AB is a Sweden-based investment company. The Company specializes in long-term owning, developing, as well as disposing listed and unlisted operating entities. Its holding portfolio comprises eight firms: Cavotec, an engineering group that delivers power transmission, distribution and control technologies to a range of areas; MedCap, which owns and develops companies involved in the Life Science sector; Mycronic, which designs and manufactures laser-based pattern generators that are used in the flexible electronics production; PartnerTech, providing product development, as well as production, logistics and aftermarket services; Vitrolife, a developer and producer of solutions for fertility treatment; XVIVO Perfusion AB, which focuses on organ, tissue and cell preservation in relation with transplantation; Investment AB Bure, which owns and manages leasing of locomotives; and Mercuri International, which offers sales and management training consultancy.
Metrics to compare | BURE | Sector Sector - Average of metrics from a broad group of related Financial sector companies | Relationship RelationshipBUREPeersSector | |
---|---|---|---|---|
P/E Ratio | 4.4x | 8.2x | 8.7x | |
PEG Ratio | 0.04 | 0.08 | 0.03 | |
Price/Book | 1.2x | 1.0x | 1.0x | |
Price / LTM Sales | 4.4x | 2.1x | 2.7x | |
Upside (Analyst Target) | - | 18.4% | 11.6% | |
Fair Value Upside | Unlock | 18.7% | 2.9% | Unlock |